Emcure Pharma launches weight loss drug Poviztra in India
Emcure Pharmaceuticals on Monday announced the commercial launch of Poviztra, a semaglutide injection for weight loss, across India. With this launch, Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, which is Novo Nordiskβs second brand of semaglutide for weight management, the company said in a statement. Poviztra will be available in…